Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2023 08:00 ET | Source: Sermonix Pharmaceuticals Inc.

Sermonix Pharmaceuticals Announces Initiation of Phase 3 ELAINE-3 Study of Lasofoxifene Plus Abemaciclib in Pre- and Post-Menopausal Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer with an ESR1 Mutation as Detected by Guardant Health’s Guardant360 CDx Liquid Biopsy

Prospective screening of subjects for ESR1 mutations will use the Guardant360 CDx blood test for companion diagnostic developmentPhase 3 study is supported by previously presented ELAINE-1 and...
November 27, 2019 02:00 ET | Source: Lung Ambition Alliance

New global survey shows misperceptions about lung cancer among the general public

LONDON, Nov. 27, 2019 (GLOBE NEWSWIRE) -- Only one in five people (22%) disagree with the statement “generally, patients with lung cancer have caused their illness through their lifestyle choices...
September 07, 2019 10:00 ET | Source: Lung Ambition Alliance

Lung Ambition Alliance unveils new initiatives to address lung cancer survival at the World Conference on Lung Cancer

New grants program to support local initiatives driven by patient organizations that have the potential to transform patient care Series of interactive and educational exhibits at the congress to...
June 19, 2018 07:38 ET | Source: Precipio, Inc.

Precipio Updates Commercial Pipeline for its ICE-COLD PCR™ Liquid Biopsy Technology

Trials underway at five laboratories and two diagnostic equipment companies NEW HAVEN, Conn., June 19, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO),...